Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scp776 in Acute Ischemic Stroke Undergoing Thrombectomy
NCT05585606Phase 2Completed
- Sponsor
- Silver Creek Pharmaceuticals
- Start
- Oct 2022
- Primary completion
- Sep 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of scp776 in ischemic stroke, sponsored by Silver Creek Pharmaceuticals. Started Oct 2022; status: completed.
02
Drugs
scp776
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05585606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585606.